Abstract
The epithelial–mesenchymal transition (EMT) plays an important role in development and cancer progression. Upon EMT, epithelial cells lose stable cell–cell adhesions and reorganize their cytoskeleton to acquire migratory activity. Recent data demonstrated that EMT drives cancer cells from the epithelial state to a hybrid epithelial/mesenchymal phenotype with retention of some epithelial markers (in particular, E-cadherin), which is important for cancer cell dissemination. In vitro studies of the effect of growth factors (in particular, epidermal growth factor (EGF)) on cultured cells can be highly advantageous for understanding the details of the early stages of EMT. The methods described in this chapter are intended for studying intermediate phenotypes of EMT. Time-lapse DIC microscopy is used for visualization of changes in morphology and motility of the cells stimulated with EGF. The transwell migration assay allows the evaluation of the migratory activity of the cells. Studying of dynamics of a fluorescently labeled actin-binding protein F-tractin-tdTomato using confocal microscopy allows detection of EGF-induced changes in the organization of the actin cytoskeleton. Live-cell imaging of cells stably expressing GFP-E-cadherin visualizes reorganization of stable tangential E-cadherin-based adherens junctions (AJs) into unstable radial AJs during the early stages of EMT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nieto MA, Huang RY, Jackson RA et al (2016) EMT: 2016. Cell 166(1):21–45
Diepenbruck M, Christofori G (2016) Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol 43:7–13
Beerling E, Seinstra D, de Wit E et al (2016) Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity. Cell Rep 14(10):2281–2288
Mani SA, Guo W, Liao MJ et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715
Morel AP, Lièvre M, Thomas C et al (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3(8):e2888
Huang RY, Guilford P, Thiery JP (2012) Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci 125:4417–4422
Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 15:178–196
Lindsey S, Langhans SA (2014) Crosstalk of oncogenic signaling pathways during epithelial–mesenchymal transition. Front Oncol 4:358
Vermeulen L, de Sousa EMF, van der Heijden M et al (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12:468–476
Taddei ML, Giannoni E, Comito G et al (2013) Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett 341:80–96
Wyckoff J, Wang W, Lin EY et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64:7022–7029
Harney AS, Arwert EN, Entenberg D et al (2015) Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov 5:932–943
Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415–428
Puisieux A, Brabletz T, Caramel J (2014) Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 16(6):488–494
Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580–584
Klymkowsky MW, Savagner P (2009) Epithelial-mesenchymal transition: a cancer researcher’s conceptual Friend and Foe. Am J Pathol 174(5):1588–1593
Ye X, Weinberg RA (2015) Epithelial–mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol 25:675–686
Burk U, Schubert J, Wellner U et al (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9(6):582–589
Kim NH, Kim HS, Li XY et al (2011) A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 195(3):417–433
Friedl P, Locker J, Sahai E et al (2012) Classifying collective cancer cell invasion. Nat Cell Biol 14(8):777–783
Rubtsova SN, Zhitnyak IY, Gloushankova NA (2015) A novel role of E-cadherin-based adherens junctions in neoplastic cell dissemination. PLoS One 10(7):e0133578
Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5(6):R217–R222
Bukholm IK, Nesland JM, Borresen-Dale AL (2000) Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients. J Pathol 190(1):15–19
Sibilia M, Kroismayr R, Lichtenberger BM et al (2007) The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75:770–787
Acknowledgment
This work was supported by the Russian Science Foundation (Grant 16-15-10288).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gloushankova, N.A., Rubtsova, S.N., Zhitnyak, I.Y. (2018). An In Vitro System to Study the Epithelial–Mesenchymal Transition In Vitro. In: Gautreau, A. (eds) Cell Migration. Methods in Molecular Biology, vol 1749. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-7701-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7701-7_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-7700-0
Online ISBN: 978-1-4939-7701-7
eBook Packages: Springer Protocols